Sopharma AD-SofiaFRA:3JR +6.36%65 Forward Dividend Yield % is 5.65% as of Jul. 04, 2026. GuruFocus rates FRA:3JR with a GF Score™ of 65/100 and a GF Value™ of €3.02 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 66 Medical Distribution companies, Sopharma AD-Sofia ranks better than 78.79% on this metric.
As of today (2026-07-04), the Forward Annual Dividend Yield of Sopharma AD-Sofia is 5.65%.
As of today (2026-07-04), the Trailing Annual Dividend Yield of Sopharma AD-Sofia is 0.00%.
FRA:3JR's Forward Dividend Yield % is ranked better than 78.79% of 66
companies
in the Medical Distribution industry
Industry Median: 2.93
vs FRA:3JR: 5.65
During the past 12 months, Sopharma AD-Sofia's average Dividends Per Share Growth Rate was 2.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sopharma AD-Sofia was 138.90% per year. The lowest was -11.40% per year. And the median was 1.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sopharma AD-Sofia Forward Dividend Yield % Related Terms
FRA:3JR vs MCK, CAH, COR: Forward Dividend Yield % Comparison
For the Medical Distribution subindustry, Sopharma AD-Sofia's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia Forward Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 5.65% mean?
Sopharma AD-Sofia (FRA:3JR) has a Forward Dividend Yield % of 5.65% as of Jul. 04, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sopharma AD-Sofia and its competitors. According to the industry distribution chart, Sopharma AD-Sofia ranks #14 out of 66 companies in the Medical Distribution industry, placing it in the top 21.2%.
Is Sopharma AD-Sofia's Forward Dividend Yield % too high?
Sopharma AD-Sofia's current Forward Dividend Yield % is 5.65%. The Medical Distribution industry median Forward Dividend Yield % is 2.93. Sopharma AD-Sofia's value of 5.65% is 92.8% above this industry median. Based on the distribution chart, Sopharma AD-Sofia ranks #14 out of 66 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sopharma AD-Sofia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Forward Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sopharma AD-Sofia ranks #14 out of 66 companies for Forward Dividend Yield %. This places Sopharma AD-Sofia in the top 21% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 2.93. Sopharma AD-Sofia's value of 5.65% is 92.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Distribution company?
The median Forward Dividend Yield % among Medical Distribution companies is 2.93, based on 66 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sopharma AD-Sofia's current Forward Dividend Yield % of 5.65% is 92.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sopharma AD-Sofia and its competitors. For the Medical Distribution industry, the median Forward Dividend Yield % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma AD-Sofia's current Forward Dividend Yield % is 5.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (FRA:3JR) is currently considered Possible Value Trap. The stock's GF Value™ is €3.02, compared to a current price of €1.84 — trading 39.1% below its estimated fair value. The current Forward Dividend Yield % is 5.65% and 92.8% above the Medical Distribution industry median of 2.93. Sopharma AD-Sofia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Sopharma AD-Sofia (FRA:3JR), the current Forward Dividend Yield % is 5.65% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma AD-Sofia (FRA:3JR) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued.
The current stock price of €1.84 is trading 39.1% below its estimated GF Value™ of €3.02.
GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.
Key valuation signals for FRA:3JR:
Forward Dividend Yield %: 5.65%
GF Value™: €3.02 vs. price of €1.84 (39.1% below fair value)
Industry Position: 92.8% above the Medical Distribution median (#14 of 66)
No single metric tells the full story. See the FRA:3JR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
65GF Score
Get the complete analysis for FRA:3JR
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3JR has been successfully added to your 